JPRN-jRCT1032230236
Recruiting
未知
Atrial Fibrillation Ablation Using a Flexible Tip Catheter with Efficient Irrigation Property-Multicenter, Randomized Controlled Trial with Multiple Output Settings
Kuroki Kenji0 sites180 target enrollmentJuly 15, 2023
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Atrial fibrillation
- Sponsor
- Kuroki Kenji
- Enrollment
- 180
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Patients who have been diagnosed with non\-valvular atrial fibrillation, who is eligible for catheter ablation, and who can be followed up at the outpatient clinic.
- •2\. Patients who are aged 20 or older and under 80 at the time of obtaining consent (regardless of gender).
- •3\. Patients who provided written consent based on their own free will as research subjects, after receiving sufficient explanation regarding participation in this study.
Exclusion Criteria
- •1\. Patients who are contraindicated for antiplatelet therapy or anticoagulant therapy.
- •2\. Patients who have been definitively diagnosed with mitral valve stenosis.
- •3\. Patients who have an implanted artificial valve.
- •4\. Patients who have undergone ventricular or atrial incision surgery within the past 4 weeks.
- •5\. Patients diagnosed with a life expectancy of less than one year due to any illness.
- •6\. Patients with left atrial thrombus.
- •7\. Patients with a left atrial diameter exceeding 50mm.
- •8\. Patients with a history of catheter ablation.
- •9\. Patients with thyroid dysfunction.
- •10\. Patients with cancer.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
CAtheter-Based Ablation of atrial fibrillation compared to conventional treatment in patients with Heart Failure with Preserved Ejection Fraction - Investigator-initiated, prospective, parallel-group, randomized, open, blinded endpoint assessment (PROBE), interventional multicenter strategy trialAtrial fibrillation and HFpEFheart failure with a preserved ejection fraction10007521NL-OMON56877Charité Universitätsmedizin Berlin150
Active, not recruiting
Not Applicable
The RAFT-AF study will examine two options for managing atrial fibrillation in heart failure patients. The two treatment options are permitting the atrial fibrillation to continue but controlling the heart rate, or to convert the atrial fibrillation rhythm back to normal and to try to maintain the heart in sinus rhythm.EUCTR2015-002516-33-SEniversity of Ottawa Heart Institute600
Completed
Not Applicable
Management of Atrial fibriLLation INcluding tailoring of anticoagulation in patients from primary care - ALL-Iabnormal heart rhythma-fib10007521NL-OMON44028Isala Klinieken Zwolle1,000
Completed
Not Applicable
Integrated management of the heart rhythm disorder atrial fibrillation, including stroke prevention with blood thinners and care for comorbidities, by the practice nurse and general practitioner in primary careAtrial fibrillation, anticoagulation, comorbidity, integrated care, primary care. Atriumfibrilleren, antistolling, comorbiditeit, integrale zorg, eerste lijn.NL-OMON23738Sponsor (verrichter) is the Isala hospital, Zwolle, the Netherlands. Performer (uitvoerder) is the Julius Center for Health Sciences and Primary Care of the University Medical Center Utrecht, The Netherlands.1,000
Completed
Not Applicable
Assessment of the atrial fibrillation ablation outcomeatrial fibrillationJPRN-UMIN000020762Keio University School of Medicine31